Driehaus Capital Management LLC

Position in WVE — Wave Life Sciences, Inc.

CIK 938206 Chicago, IL

Position in WVE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$31,624,660

-$7,750,242 QoQ

Shares Held

5,443,143

+0.2% QoQ

Ownership

2.76%

of shares outstanding

% of Portfolio

0.18%

of 13F equity value

Holder Rank

of 237 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 79% Shared 0% None 21%

Healthcare · as of Jun 30, 2026

Driehaus Capital Management LLC holds $3,602,052,293 across 59 Biotechnology names. WVE ranks #25 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DFTX	Definium Therapeutics, Inc.	6,845,276	$322,001,783
2	PRAX	Praxis Precision Medicines, Inc.	959,048	$321,079,679
3	XENE	Xenon Pharmaceuticals Inc.	4,418,557	$266,704,100
4	SYRE	Spyre Therapeutics, Inc.	2,799,166	$248,509,957
5	CRNX	Crinetics Pharmaceuticals, Inc.	6,463,551	$241,866,078
6	APGE	Apogee Therapeutics, Inc.	1,740,101	$230,963,605
7	EWTX	Edgewise Therapeutics, Inc.	4,728,623	$192,123,952
8	SEPN	Septerna, Inc.	4,433,058	$148,463,112

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$31,624,660	5,443,143	+0.2%	Shares	Sole	2026-08-14
2026-03-31	$39,374,902	5,431,021	-17.5%	Shares	Sole	2026-05-15
2025-12-31	$111,878,139	6,581,067	+4.5%	Shares	Sole	2026-02-17
2025-09-30	$46,101,799	6,298,060	-3.6%	Shares	Sole	2025-11-14
2025-06-30	$42,454,873	6,531,519	+2.7%	Shares	Sole	2025-08-14
2025-03-31	$51,377,479	6,358,599	-5.3%	Shares	Sole	2025-05-15
2024-12-31	$83,032,994	6,712,449	+14.6%	Shares	Sole	2025-02-14
2024-09-30	$48,042,652	5,858,860	+545.2%	Shares	Sole	2024-11-14
2024-06-30	$4,531,399	908,096	+62.2%	Shares	Sole	2024-08-15
2024-03-31	$3,453,941	559,796	-4.7%	Shares	Sole	2024-05-15
2023-12-31	$2,967,253	587,575	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.